Monday, June 15, 2026

U.S. and South Korea Gear Up for Major Military Drills Amid North Korean Threats

As North Korea's military threats against the South escalate, the South Korean military will conduct the 2024 National Defense Training.

Musk Associate Isaacman Becomes NASA Administrator, US Senate Confirmation Passed

Jared Isaacman, a private entrepreneur, becomes NASA's first private astronaut administrator, focusing on winning the space race against China.

Stray Kids Rewrites History, Becoming First Group to Top Billboard 200 Six Times

Stray Kids makes history with six consecutive No. 1 albums on Billboard 200, showcasing their talent and global impact in music.

Jung Eun Kim

Author's Latest

Wontek’s V-Laser Approved for Versatile Treatments in Vietnam: A Game-Changer for Aesthetic Clinics

Wontech secures medical device approval for its V-Laser in Vietnam, enhancing its product lineup and market presence in medical aesthetics.

Medipost’s Cartistem: Achieving 3000 Knee Cartilage Restoration Surgeries – A Game Changer for Osteoarthritis Treatment

Medipost's Cartistem therapy reaches 3,000 procedures for cartilage restoration, proving its safety and efficacy for knee osteoarthritis.

Why Centrum Multivitamins Are Backed by 32 Clinical Studies: A Deep Dive into Their Proven Benefits

Centrum multivitamins stand out for their extensive research backing, showing benefits in cancer risk reduction and cognitive function.

Celltrion’s Remsima Surpasses 1 Trillion KRW in Sales for 2nd Consecutive Year: What’s Driving Its Success?

Celltrion's Remsima treatment surpasses 1 trillion KRW in sales, driven by European market growth and new liquid formulation.

Samsung Biologics Partners with CEPI: A Game-Changer for Global Vaccine Production

Samsung Biologics partners with CEPI to enhance vaccine production for pandemics, aiming for rapid global supply and health security.

HM15275 Clinical Trials: What You Need to Know About This Groundbreaking Obesity Treatment

Hanmi Pharmaceutical's HM15275 enters Phase 2 trial, aiming to revolutionize obesity treatment and diabetes management by 2030.

Celltrion’s Remsima SC: The Leading Autoimmune Drug with 68% Market Share in Europe

Celltrion's treatments for autoimmune diseases and cancer maintain strong market positions in Europe, bolstered by stable prescriptions and new products.

Pneumonia Death Rates in South Korea: Why Vaccination is Crucial for High-Risk Groups

Pneumonia is South Korea's third leading cause of death; prevention is crucial, especially for high-risk groups after influenza.

Samsung Bioepis Expands SB15 Eylea Rival: Licensing Pact Targets Global Markets as Original Drug Hits $10.5B Sales

Samsung Bioepis has secured a licensing deal for its ophthalmic treatment SB15, expanding access in international markets outside the US and Canada.

How Celltrion is Tackling U.S. Tariff Risks with New Production Facility in 2026

Celltrion addresses tariff risks by acquiring a U.S. facility, ensuring product supply and implementing strategies to mitigate uncertainties.

Why a High-Concentration Albumin Product Is Expanding Nationwide After 13 Straight Sellouts

Daewon Pharmaceutical expands offline distribution of Albumin King to major department stores across Korea, boosting consumer access and sales.

Revolutionary mRNA Cancer Treatment Shows 49% Survival Improvement: What You Need to Know

A study shows mRNA-based cancer treatments significantly improve survival rates, marking a breakthrough in precision therapy for melanoma.

Eli Lilly vs. Novo Nordisk: A $1.2 Billion Bet Reveals Two Very Different Futures for Obesity Drugs

Eli Lilly and Novo Nordisk are pursuing different strategies in the obesity treatment market, focusing on expansion versus core strengths.

Why Ebola Now? SK Bioscience Joins a $30 Million Global Push to Rethink Ebola Vaccine Production

SK Bioscience secures funding to enhance Ebola vaccine production, improving yield and stability for better accessibility amid outbreaks.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.